3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
78
Myelodysplastic Syndromes
75
Precursor Cell Lymphoblastic Leukemia-Lymphoma
70
Leukemia, Lymphocytic, Chronic, B-Cell
58
Leukemia
55
Hodgkin Disease
55
Lymphoma, Non-Hodgkin
54
Lymphoma
48
Multiple Myeloma
45
Myeloproliferative Disorders
41
Lymphoma, Follicular
40
Graft vs Host Disease
38
Lymphoma, Mantle-Cell
36
Lymphoma, Large B-Cell, Diffuse
36
Leukemia, Myelomonocytic, Chronic
36
Lymphoma, B-Cell, Marginal Zone
35
Leukemia, Myeloid, Accelerated Phase
34
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
33
Congenital Abnormalities
33
Burkitt Lymphoma
33
Leukemia, Myeloid, Chronic-Phase
29
Primary Myelofibrosis
28
Hematologic Neoplasms
28
Neoplasms, Plasma Cell
24
Lymphoma, Large-Cell, Immunoblastic
24
Blast Crisis
24
Waldenstrom Macroglobulinemia
20
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
19
Myelodysplastic-Myeloproliferative Diseases
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Interventions
Mitomycin
2
Capecitabine
2
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Lansoprazole
1
Ipilimumab
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cytoreduction Surgical Procedures
1
Clarithromycin
1
CTLA-4 Antigen
1
Bromelains
1
Amoxicillin
1
Alemtuzumab
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pseudomyxoma Peritonei
×
Tacrolimus
×
Clear all
NCT06084780
2026-06-05
TRANSCAPE
Case Comprehensive Cancer Center
Phase 2
Not yet recruiting
20 enrolled